This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for ACLX to draw a line in its place.
ACLX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 28 April 2026.
DateInsiderTypeSharesValue
17 Nov 2025Heery ChristopherCHIEF MEDICAL OFFICERSell340$31K
15 Oct 2025Gilson MichelleCHIEF FINANCIAL OFFICERSell5,364$488K
06 Oct 2025Gilson MichelleCHIEF FINANCIAL OFFICERSell1,064$92K
03 Oct 2025Gilson MichelleCHIEF FINANCIAL OFFICERSell4,882$420K
30 Sep 2025Heery ChristopherCHIEF MEDICAL OFFICERSell21,034$1.71M
29 Sep 2025Heery ChristopherCHIEF MEDICAL OFFICERSell73$6K
26 Sep 2025Heery ChristopherCHIEF MEDICAL OFFICERSell12,396$993K
19 Sep 2025Heery ChristopherCHIEF MEDICAL OFFICERSell300$24K
18 Sep 2025Heery ChristopherCHIEF MEDICAL OFFICERSell3,343$267K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
28 Apr 2026Galligan Andrew HDirectorOther5,000
28 Apr 2026Lubner David CharlesDirectorOther21,659
28 Apr 2026Elghandour RamiSEE REMARKSOther692,551
28 Apr 2026Heery ChristopherCHIEF MEDICAL OFFICEROther23,749